Technology | Radiation Dose Management | August 07, 2017

Virtual Phantoms Inc. Releases VirtualDose-IR

Software tool collects organ dose data from interventional radiology procedures

Virtual Phantoms Inc. Releases VirtualDose-IR

August 7, 2017 — Virtual Phantoms Inc. announced the release of VirtualDoseIR, a tool for assessing organ dose from interventional radiology (IR) procedures. Like its VirtualDose CT product for computed tomography, VirtualDoseIR combines a family of anatomically realistic human phantoms, advanced Monte Carlo simulations, and an easy-to-use web interface to provide realistic calculations of dose to a diverse patient population.

VirtualDoseIR enables users to accurately compute doses to radiosensitive organs for a broad range of the patient population, including those outside the “average” body size, pediatric patients from newborn through adolescence, and patients who are pregnant.

In recent years, IR procedures have expanded beyond the traditional cardiovascular applications to many other specialty areas, and so their overall use has increased significantly, today contributing more than 14 percent of all medical radiation dose in the United States. Long exposure times can subject patients to acute injuries to the skin and other tissues, but the large accumulated doses pose a long-term radiation risk that can be monitored and managed. With continued growth, it is likely that regulatory attention will turn to IR in the future. 

VirtualDoseIR has been designed with clinical practice in mind. The web interface allows the user to easily select the parameters of the procedure setup, including field size, kVp, filtration, position and direction. As these are selected, the display updates to provide a visualization of the exam field on the patient to ensure it matches the procedure performed. And because different machines may track different information, the system will accept X-ray output in terms of dose area product (DAP) or air kerma rate and exposure time.

For more information: www.virtualphantoms.com

Related Content

An example of Philips’ TrueVue technology, which offers photo-realistic rendering and the ability to change the location of the lighting source on 3-D ultrasound images. In this example of two Amplazer transcatheter septal occluder devices in the heart, the operator demonstrating the product was able to push the lighting source behind the devices into the other chamber of the heart. This illuminated a hole that was still present that the occluders did not seal. Photo by Dave Fornell

An example of Philips’ TrueVue technology, which offers photo-realistic rendering and the ability to change the location of the lighting source on 3-D ultrasound images. In this example of two Amplazer transcatheter septal occluder devices in the heart, the operator demonstrating the product was able to push the lighting source behind the devices into the other chamber of the heart. This illuminated a hole that was still present that the occluders did not seal. Photo by Dave Fornell

Feature | Interventional Radiology | April 03, 2020 | By Katie Caron
A new year — and decade — offers the opportunity to reflect on the advancements and challenges of years gone by and p
COVID-19 outbreak in Seattle cancels SIR 2020 meeting. Interventional radiology meeting cancelled. #COVID19 #coronavirus #2019nCoV
News | Interventional Radiology | March 09, 2020 | Melinda Taschetta-Millane
March 9, 2020 — As the novel coronavirus (COVID-19) slowly spreads across the globe, more industry conferences are de
DSA image obtained approximately 24 hours after 1 mg/h IA tPA infusion, 500 U/h heparin via peripheral IV, and daily oral aspirin (81 mg) shows improved perfusion of digital arteries, albeit with suboptimal vascular blush of distal second and third phalanges. Photo courtesy of ARRS

DSA image obtained approximately 24 hours after 1 mg/h IA tPA infusion, 500 U/h heparin via peripheral IV, and daily oral aspirin (81 mg) shows improved perfusion of digital arteries, albeit with suboptimal vascular blush of distal second and third phalanges. Photo courtesy of ARRS

News | Interventional Radiology | February 11, 2020
February 11, 2020 — An ahead-of-print...
New SIR position statement and quality documents highlight interventional radiology effective use of nonsurgical ablation to treat kidney cancer in selected patients
News | Interventional Radiology | February 04, 2020
February 4, 2020 — For some patients, kidney cancer can be effectively treated without surgery, according to the Soci
Smart Speaker Technology Harnessed for Hospital Medical Treatments
News | Interventional Radiology | April 10, 2019
Smart speakers customarily used in your living room can act as an aid to physicians in hospital operating rooms,...
NZ Technologies Announces First Peer-Reviewed Paper on TIPSO AirPad
News | Interventional Radiology | March 25, 2019
NZ Technologies Inc. announced the first published clinical review on its TIPSO technology’s ability to provide...
Embolx Announces FDA Clearance of Next-generation Sniper Balloon Occlusion Microcatheter
Technology | Interventional Radiology | June 29, 2018
Embolx Inc. has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its next-generation...
Guerbet Launches Pair of Microcatheters for Interventional Radiology Procedures
Technology | Interventional Radiology | May 23, 2018
Guerbet LLC USA announced the upcoming launch of SeQure and DraKon, two novel microcatheters for tumor and vascular...
U.S. First Lady Melania Trump Undergoes Interventional Radiology Embolization Procedure
News | Interventional Radiology | May 15, 2018
U.S. First Lady Melania Trump underwent an interventional radiology embolization procedure to treat a benign kidney...